Advocacy Pharmaceutical Programs Safety 
Cannabis Law Report
DECEMBER 3, 2021
–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We Ganaxolone was generally well-tolerated and no new safety findings emerged in the LGS subgroup. ET (12:00 p.m.
MMJ Recs
NOVEMBER 17, 2023
The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. The state’s program has evolved to meet the needs of patients and the demands of the industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
SEPTEMBER 8, 2021
Responsible policy prioritizes public health and safety and promotes the viability of both California’s legal cannabis industry and the legal hemp industry. . Such a policy includes equal safety testing requirements to protect public health.
NORML
AUGUST 26, 2019
So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California. And it took extensive, concerted efforts from marijuana law reform organizations like NORML to negotiate with Virginia’s Republican Party to get the program finally running.
Cannabis Law Report
JANUARY 5, 2022
Registered 23,000 patients for our Compassionate Pricing Program through Spectrum Therapeutics. Trained 93% of Canopy Growth employees on our pharmacovigilance program. Recorded 0 safety-related product recalls globally.
Cannabis Law Report
FEBRUARY 1, 2022
Rade holds a BA from the University of Guelph and graduated from the General Management Program at Harvard Business School. Ben Quirin has over 20 years of global leadership in the telecommunications, technology and pharmaceutical sectors, where he has launched new products and led business development in new and emerging markets.
Veriheal
AUGUST 31, 2020
Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.
Expert insights. Personalized for you.
52 
Let's personalize your content